Cargando…
Investigating The Correction of IVS II-1 (G> A) Mutation in HBB Gene in TLS-12 Cell Line Using CRISPR/Cas9 System
OBJECTIVE: Beta-thalassemia is a group of inherited hematologic. The most HBB gene variant among Iranian beta-thalassemia patients is related to two mutations of IVSII-1 (G>A) and IVSI-5 (G>C). Therefore, our aim of this study is to use the knock in capability of CRISPR Cas9 system to investig...
Autores principales: | Servatian, Nazli, Abroun, Saeid, Shahzadeh Fazeli, Seyed Abolhassan, Soleimani, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105294/ https://www.ncbi.nlm.nih.gov/pubmed/37038697 http://dx.doi.org/10.22074/CELLJ.2022.560725.1118 |
Ejemplares similares
-
Integrative Analysis of CRISPR/Cas9 Target Sites in the Human HBB Gene
por: Luo, Yumei, et al.
Publicado: (2015) -
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
por: Xu, Peng, et al.
Publicado: (2015) -
AntagomiR-19a Induced Better Responsiveness to Bortezomib
in Myeloma Cell Lines
por: Kazemi, Azam, et al.
Publicado: (2021) -
A phenol amine molecule from Salinivenus iranica acts as the inhibitor of cancer stem cells in breast cancer cell lines
por: Safarpour, Atefeh, et al.
Publicado: (2023) -
PCR-DGGE analysis of fungal community in manufacturing process of a traditional Iranian cheese
por: Ramezani, Mohaddeseh, et al.
Publicado: (2018)